Emtriva
NDC Package 46014-0601-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Emtriva is emtricitabine is used with other HIV medications to help control HIV infection. Marketed by Excella Gmbh, this product is identified by NDC 46014-0601 and is authorized under FDA application NDA021500.

Identification & Billing

NDC Package Code
46014-0601-1
Package Description
30 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
46014-0601
11-Digit Billing Format
46014060101
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Emtriva
Dosage Form
-
Usage Information
Emtricitabine is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Emtricitabine belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors-NRTI. Emtricitabine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

Regulatory & Marketing

Labeler Name
Excella Gmbh
FDA Application #
NDA021500
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-02-2003
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 46014-0601-1 identifies a specific commercial package of 30 capsule in 1 bottle, plastic of Emtriva, labeled by Excella Gmbh. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Excella Gmbh on July 02, 2003. The current certification is valid through December 31, 2018.

What are the primary indications for this medication?

Emtricitabine is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Emtricitabine belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors-NRTI. Emtricitabine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

How is this Excella Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 46014060101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
46014-0601-1
11-Digit CMS (5-4-2)
46014-0601-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.